UNSPSC 51102828: Cetylpyridinium chloride/chloroxylenol/hydrocortisone/triacetin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102828 Cetylpyridinium chloride/chloroxylenol/hydrocortisone/triacetin is a Commodity code that does not align with the recent state and local opportunities tagged under it. The Illinois Department of Public Health's MMCAP piggyback award in August 2026 was for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and the Seminole County, Florida IFB from June 2026 sought Naloxone and safe drug deactivation systems — neither of which matches the nominal scope of this specialized topical or antifungal compound. The code shows no recent activity actually procuring the product it nominally describes.

The geographic data available is limited to Florida and Illinois based on the two opportunities present, though the mismatch between the code name and the work being solicited suggests these opportunities may be miscoded rather than representative of genuine activity under this Commodity. No other recent opportunities, issuing-body patterns, or decision-relevant procurement signals emerge from the source material for this code.